Experiment 956337
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | HALAMA,P:. (1991). JUDGEMENT OF WELL-BEING AND PSYCHOMETRIC TESTS IN PATIENTS FROM A NEUROLOGICAL PRACTICE TREATED WITH GINKGO.. 133() |
| Amount utilized | |
| Compound isolated | |
| Disease | THE OBJECTIVE OF THE STUDY WAS TO TEST A SPECIAL GINKGO EXTRACT ON IMPROVEMENT OF WELL-BEING AND CEREBRAL FUNCTIONAL CAPACITY. THIS WAS A RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL LASTING FOR 13 WEEKS. FIFTY PATIENTS WITH DEGENERATIVE AND VASCULAR DEMENTIA WERE INCLUDED IN THE STUDY. THREE TABLETS OF 50 MG EXTRACT EACH OR THREE PLACEBO TABLETS WERE GIVEN DAILY. END POINTS WERE PSYCHOMIMETIC TESTS AND JUDGEMENT SCALES. THERE WERE PREMATURE DISCONTINUATIONS IN 3 PATIENTS FROM THE PLACEBO GROUP AND 5 PATIENTS FROM THE ACTIVE TREATMENT GROUP. UNDESIRED EFFECTS WERE SEEN UNDER PLACEBO TREATMENT ONCE, UNDER ACTIVE TREATMENT TWICE. SIGNIFICANT DIFFERENCES BETWEEN BOTH GROUPS AFTER 12 WEEKS FOR 7 OUT OF 11 TYPICAL SYMPTOMS OF CEREBRAL INSUFFICIENCY IN FAVOR OF THE ACTIVE TREATMENT GROUP WERE SEEN. THE ACTIVE TREATMENT GROUP WAS SIGNIFICANTLY FASTER IN CARRYING OUT THE FIGURE CONNECTION TEST AFTER 6 AND 12 WEEKS: IN THE SYNDROME SHORT TEST, THE COMAPARISON OF PLACEBO AND ACTIVE TREATMENT GROUP AS WELL AS THE TREATMENT COURSE SHOWS SIGNIFICANTLY BETTER RESULTS IN THE ACTIVE TREATMENT GROUP. THE CONCLUSION WAS THAT THE TREATMENT GROUP WITH GINKGO EXTRACT RESULTED IN AN IMPROVEMENT IN THE CEREBRAL FUNCTIONAL CAPACITY OF TYPICAL SYMPTOMS OF CEREBRAL INSUFFICIENCY IN PATIENTS WITH DEGENERATIVE AND VASCULAR DEMENTIA. |
| Dose amount | 150.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |